5.70
price down icon2.40%   -0.14
after-market 시간 외 거래: 5.71 0.010 +0.18%
loading
전일 마감가:
$5.84
열려 있는:
$5.57
하루 거래량:
764.76K
Relative Volume:
0.63
시가총액:
$293.47M
수익:
$3.64M
순이익/손실:
$-87.37M
주가수익비율:
-1.3869
EPS:
-4.11
순현금흐름:
$-86.46M
1주 성능:
-15.30%
1개월 성능:
+2.89%
6개월 성능:
+105.78%
1년 성능:
-52.42%
1일 변동 폭
Value
$5.39
$5.77
1주일 범위
Value
$5.39
$6.72
52주 변동 폭
Value
$2.10
$13.52

Verastem Inc Stock (VSTM) Company Profile

Name
명칭
Verastem Inc
Name
전화
(781) 292-4200
Name
주소
117 KENDRICK STREET, NEEDHAM, MA
Name
직원
0
Name
트위터
@VerastemOncolog
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
VSTM's Discussions on Twitter

VSTM을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
VSTM
Verastem Inc
5.70 293.47M 3.64M -87.37M -86.46M -4.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 68.39B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Verastem Inc Stock (VSTM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-24 재확인 H.C. Wainwright Buy
2024-12-31 재확인 BTIG Research Buy
2024-09-30 개시 Guggenheim Buy
2023-11-21 재개 BTIG Research Buy
2023-09-27 개시 B. Riley Securities Buy
2023-06-15 업그레이드 Mizuho Neutral → Buy
2022-09-07 재개 Alliance Global Partners Buy
2022-04-29 재개 Cantor Fitzgerald Overweight
2022-04-14 개시 RBC Capital Mkts Outperform
2022-03-09 개시 Truist Buy
2021-07-01 개시 Alliance Global Partners Buy
2021-05-24 업그레이드 BTIG Research Neutral → Buy
2019-06-20 다운그레이드 BTIG Research Buy → Neutral
2019-05-10 다운그레이드 Raymond James Outperform → Mkt Perform
2018-07-13 개시 BTIG Research Buy
2018-05-02 개시 Seaport Global Securities Buy
2018-03-08 개시 B. Riley FBR, Inc. Buy
2017-09-07 재확인 H.C. Wainwright Buy
2017-04-13 개시 Oppenheimer Outperform
2017-03-24 재확인 H.C. Wainwright Buy
2015-09-29 다운그레이드 Cantor Fitzgerald Buy → Hold
2015-09-29 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2015-09-29 다운그레이드 Jefferies Buy → Hold
2015-09-29 다운그레이드 Raymond James Strong Buy → Outperform
2015-09-28 다운그레이드 Mizuho Buy → Neutral
2015-09-28 다운그레이드 ROTH Capital Buy → Neutral
2015-09-09 개시 Raymond James Strong Buy
2015-05-12 재확인 UBS Buy
2015-04-08 개시 H.C. Wainwright Buy
2015-01-23 재확인 ROTH Capital Buy
2014-07-08 재개 Oppenheimer Perform
2014-02-11 개시 Mizuho Buy
모두보기

Verastem Inc 주식(VSTM)의 최신 뉴스

pulisher
Apr 02, 2025

Verastem Oncology Reports Progress in Cancer Treatments - TipRanks

Apr 02, 2025
pulisher
Mar 28, 2025

Verastem (NASDAQ:VSTM) Upgraded at StockNews.com - MarketBeat

Mar 28, 2025
pulisher
Mar 27, 2025

Wall Street Analysts Believe Verastem (VSTM) Could Rally 100.94%: Here's is How to Trade - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

(VSTM) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Mar 27, 2025
pulisher
Mar 25, 2025

Verastem Oncology Announces Multiple Presentations Focused on RAS/MAPK Pathway Inhibition at AACR Annual Meeting 2025 - Yahoo Finance

Mar 25, 2025
pulisher
Mar 24, 2025

Verastem CFO Daniel Calkins sells shares worth $630 - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Verastem CFO Daniel Calkins sells shares worth $630 By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

H.C. Wainwright lifts Verastem stock price target to $10 By Investing.com - Investing.com Canada

Mar 24, 2025
pulisher
Mar 24, 2025

Guggenheim lifts Verastem stock target to $14, maintains buy By Investing.com - Investing.com Canada

Mar 24, 2025
pulisher
Mar 24, 2025

H.C. Wainwright lifts Verastem stock price target to $10 - Investing.com India

Mar 24, 2025
pulisher
Mar 23, 2025

Royal Bank of Canada Lowers Verastem (NASDAQ:VSTM) Price Target to $14.00 - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

RBC Cuts Price Target on Verastem to $14 From $16, Maintains Outperform Rating -March 21, 2025 at 08:40 am EDT - Marketscreener.com

Mar 21, 2025
pulisher
Mar 21, 2025

BTIG maintains $20 target, Buy rating on Verastem stock By Investing.com - Investing.com Canada

Mar 21, 2025
pulisher
Mar 21, 2025

Verastem: Q4 Earnings Snapshot - Midland Daily News

Mar 21, 2025
pulisher
Mar 20, 2025

Verastem director Brian Stuglik sells shares worth $4,121 By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

Verastem Unveils Strategic Plans in New Presentation - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

Verastem Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Verastem, Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Verastem Inc. (VSTM) reports earnings - Quartz

Mar 20, 2025
pulisher
Mar 20, 2025

Verastem Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates - Bluefield Daily Telegraph

Mar 20, 2025
pulisher
Mar 20, 2025

Verastem director Robert Gagnon sells shares worth $1,973 By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mar 20, 2025
pulisher
Mar 20, 2025

Verastem, Inc. (NASDAQ:VSTM) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Verastem CEO sells shares worth $1,695 By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Verastem director Robert Gagnon sells shares worth $1,973 - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Verastem director Brian Stuglik sells shares worth $4,121 - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Verastem (NASDAQ:VSTM) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Mar 18, 2025
pulisher
Mar 14, 2025

Verastem Inc expected to post a loss of 81 cents a shareEarnings Preview - TradingView

Mar 14, 2025
pulisher
Mar 13, 2025

Verastem to Present at Keystone Symposia on PI3 Kinase - AOL.com

Mar 13, 2025
pulisher
Mar 11, 2025

Verastem: Upcoming PDUFA, But I Remain Cautious (NASDAQ:VSTM) - Seeking Alpha

Mar 11, 2025
pulisher
Mar 11, 2025

Rhumbline Advisers Acquires 10,352 Shares of Verastem, Inc. (NASDAQ:VSTM) - Defense World

Mar 11, 2025
pulisher
Mar 08, 2025

Why the Global Cancer Market Could Surpass $900 Billion-And the Stocks Leading the Charge - The Malaysian Reserve

Mar 08, 2025
pulisher
Mar 08, 2025

Why the Global Cancer Market Could Surpass $900 Billion—And the Stocks Leading the Charge - Morningstar

Mar 08, 2025
pulisher
Mar 06, 2025

Verastem (VSTM) Expected to Announce Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Objective long/short (VSTM) Report - Stock Traders Daily

Mar 06, 2025
pulisher
Mar 05, 2025

Verastem Inc (NASDAQ: VSTM) Stock Forecast: Bearish Expectations Portend -120.34% Downside In 2025 - Stocks Register

Mar 05, 2025
pulisher
Mar 04, 2025

Verastem (NASDAQ:VSTM) Stock Price Passes Above 200 Day Moving Average – Should You Sell? - Defense World

Mar 04, 2025
pulisher
Feb 23, 2025

Verastem, Inc. (NASDAQ:VSTM) Given Consensus Rating of “Buy” by Brokerages - Defense World

Feb 23, 2025
pulisher
Feb 20, 2025

Verastem Oncology Announces Multiple Data Presentations At Society Of Gynecologic Oncology 2025 Annual Meeting On Women's Cancer - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Verastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer - Business Wire

Feb 20, 2025
pulisher
Feb 19, 2025

VSTM Up as NDA for Ovarian Cancer Combo Gets FDA's Priority Review Tag - MSN

Feb 19, 2025
pulisher
Feb 13, 2025

When the Price of (VSTM) Talks, People Listen - Stock Traders Daily

Feb 13, 2025
pulisher
Feb 10, 2025

Financial Snapshot: Analyzing Verastem Inc (VSTM)’s Key Ratio Metrics - The Dwinnex

Feb 10, 2025
pulisher
Feb 08, 2025

Verastem Inc (NASDAQ: VSTM) Shares Fall By -4.77 Percent In The Past Week, But How Long Will It Last? - Marketing Sentinel

Feb 08, 2025

Verastem Inc (VSTM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
자본화:     |  볼륨(24시간):